001     310355
005     20260310154110.0
024 7 _ |a 10.1172/jci.insight.190283
|2 doi
024 7 _ |a pmid:41797715
|2 pmid
037 _ _ |a DKFZ-2026-00555
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Wanner, Nicola
|b 0
245 _ _ |a Lysine-specific histone demethylase 1a regulates nephron development and long-term transcriptional programming.
260 _ _ |a Ann Arbor, Michigan
|c 2026
|b JCI Insight
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1773153658_3075694
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Low nephron endowment constitutes a risk factor for hypertension and renal disease. Epigenetic regulation is crucial for nephron progenitor cell differentiation, affecting nephron number and renal function. The role of many epigenetic modulators, such as Lysine-specific histone demethylase 1a (LSD1 or KDM1A), remains unclear. We used Kdm1a-KO mice to demonstrate that Kdm1a depletion in nephron progenitor cells results in reduced kidney size in neonates and led to glomerulosclerosis, proteinuria, and renal cysts in adults. Notably, Kdm1a deletion in podocytes or tubular cells did not replicate these effects. CRISPR/Cas9-mediated KDM1A deletion in human kidney organoids caused cyst formation and altered gene expression, with snRNA-seq revealing downregulation of podocyte genes and upregulation of metabolic genes. The presence of noncoding RNAs indicated roles in cell proliferation. Our study reveals the critical role of Kdm1a function in nephron development and highlights its affect on transcriptional programming for long-term renal function and susceptibility to cyst formation.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Chronic kidney disease
|2 Other
650 _ 7 |a Development
|2 Other
650 _ 7 |a Epigenetics
|2 Other
650 _ 7 |a Nephrology
|2 Other
650 _ 7 |a KDM1a protein, mouse
|0 EC 1.14.11.-
|2 NLM Chemicals
650 _ 7 |a Histone Demethylases
|0 EC 1.14.11.-
|2 NLM Chemicals
650 _ 7 |a KDM1A protein, human
|0 EC 1.5.-
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Nephrons: growth & development
|2 MeSH
650 _ 2 |a Nephrons: metabolism
|2 MeSH
650 _ 2 |a Nephrons: pathology
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Mice, Knockout
|2 MeSH
650 _ 2 |a Histone Demethylases: genetics
|2 MeSH
650 _ 2 |a Histone Demethylases: metabolism
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Podocytes: metabolism
|2 MeSH
650 _ 2 |a Cell Differentiation: genetics
|2 MeSH
650 _ 2 |a Cell Proliferation: genetics
|2 MeSH
650 _ 2 |a Gene Expression Regulation, Developmental
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Epigenesis, Genetic
|2 MeSH
650 _ 2 |a Organoids
|2 MeSH
700 1 _ |a Keller, Julia
|b 1
700 1 _ |a Liaukouskaya, Nastassia
|b 2
700 1 _ |a Andrieux, Geoffroy
|b 3
700 1 _ |a Laufer, Sandra D
|b 4
700 1 _ |a Rogg, Manuel
|b 5
700 1 _ |a Bork, Tillmann
|b 6
700 1 _ |a Liang, Wei
|b 7
700 1 _ |a Braun, Fabian
|b 8
700 1 _ |a Haas, Fabian
|b 9
700 1 _ |a Wong, Milagros N
|b 10
700 1 _ |a Puelles, Victor G
|b 11
700 1 _ |a Gies, Sydney E
|b 12
700 1 _ |a Meyer, Charlotte
|b 13
700 1 _ |a Boerries, Melanie
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Helmstädter, Martin
|b 15
700 1 _ |a Kretz, Oliver
|b 16
700 1 _ |a Hild, Iris
|b 17
700 1 _ |a Metzger, Eric
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Schüle, Roland
|b 19
700 1 _ |a Bechtel-Walz, Wibke
|b 20
700 1 _ |a Huber, Tobias B
|b 21
773 _ _ |a 10.1172/jci.insight.190283
|g Vol. 11, no. 5, p. e190283
|0 PERI:(DE-600)2874757-4
|n 5
|p e190283
|t JCI insight
|v 11
|y 2026
|x 2379-3708
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2026
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b JCI INSIGHT : 2022
|d 2025-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2025-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2025-09-13T16:28:13Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2025-09-13T16:28:13Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2025-09-13T16:28:13Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2025-09-13T16:28:13Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-11-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-11-11
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b JCI INSIGHT : 2022
|d 2025-11-11
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-11-11
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-11-11
920 1 _ |0 I:(DE-He78)FR01-20160331
|k FR01
|l DKTK Koordinierungsstelle Freiburg
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)FR01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21